Cara Therapeutics reported $10.77M in Trade Debtors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US USD 56.14M 12.75M
Acelrx Pharmaceuticals ACRX:US USD 512K 148K
Cara Therapeutics CARA:US USD 10.77M 1.6M
Chugai Pharma 4519:JP JPY 514.28B 238.86B
Depomed DEPO:US USD 44.68M 3.86M
Endo International Ordinary Shares ENDP:US USD 425.95M 75.15M
Halozyme Therapeutics HALO:US USD 233.3M 43.93M
Horizon Pharma HZNP:US USD 646.39M 26.92M
Pacira Pharmaceuticals PCRX:US USD 93.47M 2.37M
Revance Therapeutics RVNC:US USD 11.73M 6.14M
Supernus Pharmaceuticals SUPN:US USD 164.09M 6.02M
Teva Pharmaceutical Industries TEVA:US USD 3.73B 741M
Vanda Pharmaceuticals VNDA:US USD 29.35M 547K